trending Market Intelligence /marketintelligence/en/news-insights/trending/t2JyR0end5aTpwGNwTkXHA2 content esgSubNav
In This List

China SXT Pharmaceuticals closes IPO

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


China SXT Pharmaceuticals closes IPO

China SXT Pharmaceuticals Inc. closed its IPO, issuing 2,546,275 common shares priced at $4 each.

The China-based company, which develops, manufactures and sells traditional Chinese medicine pieces, known as TCMP, raised gross proceeds of $10.2 million.

The company plans to use the net proceeds to expand its manufacturing facility and employee base and for funding development and research of new drugs. According to China SXT, the amount raised will also be used as general working capital.

The shares sold under the IPO will start trading Jan. 4 on the Nasdaq Capital Market under the symbol SXTC.

Boustead Securities LLC acted as the sole underwriter for the offering. Hunter Taubman Fischer & Li LLC acted as legal counsel.